Interazioni tra farmaci
Denosumab + Rozanolixizumab
Gravità: Moderata
Denosumab and Rozanolixizumab: moderate interaction.
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
Sintesi
Rozanolixizumab blocks the neonatal Fc receptor, reducing IgG recycling and shortening IgG half-life. Denosumab is an IgG2 antibody, so its exposure and antiresorptive effect could theoretically be reduced. Clinical data are lacking.
Cosa significa questa interazione in parole semplici
Denosumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Denosumab belongs to Oncology; Rozanolixizumab belongs to Miscellaneous.
Perché avviene
FcRn blockade accelerates IgG catabolism and may lower denosumab concentrations.
Cosa fare
Monitor bone turnover markers and bone density for loss of effect. Consider alternative non-antibody antiresorptive therapy if denosumab is needed long term.
Cosa chiedere al farmacista
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Denosumab e Rozanolixizumab, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altre interazioni di Denosumab
- Abatacept + Denosumab Moderata
- Adalimumab + Denosumab Moderata
- Alefacept + Denosumab Moderata
- Alemtuzumab + Denosumab Moderata
- Anakinra + Denosumab Moderata
- Azacitidine + Denosumab Moderata
Altre interazioni di Rozanolixizumab
- Rozanolixizumab + Upadacitinib Maggiore
- Abatacept + Rozanolixizumab Moderata
- Adalimumab + Rozanolixizumab Moderata
- Ado-trastuzumab + Rozanolixizumab Moderata
- Basiliximab + Rozanolixizumab Moderata
- Bevacizumab + Rozanolixizumab Moderata
Domande frequenti
Can I take Denosumab with Rozanolixizumab?
MediHelp rates the interaction as moderate. Denosumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rozanolixizumab blocks the neonatal Fc receptor, reducing IgG recycling and shortening IgG half-life. Denosumab is an IgG2 antibody, so its exposure and antiresorptive effect could theoretically be reduced. Clinical data are lacking.
How serious is the interaction between Denosumab and Rozanolixizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor bone turnover markers and bone density for loss of effect. Consider alternative non-antibody antiresorptive therapy if denosumab is needed long term.
What other medicines interact with Denosumab?
MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
